These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1512695)

  • 41. Declining seroprevalence of HIV infection among paediatric inpatients.
    Daga SR; Verma B; Gosavi DV; Kapse V; Shinde N
    Trop Doct; 2007 Oct; 37(4):233-5. PubMed ID: 17988490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Field evaluation of immunoglobulin G antibody capture tests for HIV-1 and HIV-2 antibodies in African serum, saliva and urine.
    Klokke AH; Ocheng D; Kalluvya SE; Nicoll AG; Laukamm-Josten U; Parry JV; Mortimer PP; Connell JA
    AIDS; 1991 Nov; 5(11):1391-2. PubMed ID: 1768391
    [No Abstract]   [Full Text] [Related]  

  • 43. 1989-1996 HIV-1 prevalence trends among different risk groups in Gulu District, North Uganda.
    Fabiani M; Blè C; Grivel P; Lukwiya M; Declich S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):514. PubMed ID: 9715850
    [No Abstract]   [Full Text] [Related]  

  • 44. Prevalence of antibody to the human immunodeficiency virus among clinical laboratory specimens: findings from a survey of primary care physicians.
    Fernando NH; Petersen LR; Conway GA; Critchley SE
    J Acquir Immune Defic Syndr (1988); 1994 Feb; 7(2):177-81. PubMed ID: 8301529
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Retrovirus and blood transfusion].
    Barrera JM; Ercilla MG; Gil BC
    Sangre (Barc); 1993 Jun; 38(3):187-92. PubMed ID: 8105545
    [No Abstract]   [Full Text] [Related]  

  • 46. Seroepidemiological survey of HIV-1 and HIV-2 infections in the five regions of Ivory Coast.
    Gershy-Damet GM; Koffi K; Soro B; Coulibaly A; Koffi D; Sangare V; Josseran R; Guelain J; Aoussi E; Odehouri K
    AIDS; 1991 Apr; 5(4):462-3. PubMed ID: 1647793
    [No Abstract]   [Full Text] [Related]  

  • 47. HIV-1 and HIV-2 antibodies in Nigerian populations with high- and low-risk behaviour patterns.
    Williams EE; Mohammed I; Chikwem JO; Akinsete R; Udofia O; Schulze G; Fleming AF; Hunsmann G
    AIDS; 1990 Oct; 4(10):1041-2. PubMed ID: 2261124
    [No Abstract]   [Full Text] [Related]  

  • 48. Usefulness of oral mucosal transudate for HIV antibody testing.
    Martinez P; Ortiz de Lejarazu R; Eiros JM; Rodriguez-Torres A
    JAMA; 1997 May; 277(20):1592. PubMed ID: 9168282
    [No Abstract]   [Full Text] [Related]  

  • 49. Seroprevalence of HIV-1 and HIV-2 infection among children diagnosed with protein-calorie malnutrition in Nigeria.
    Fischer GD; Rinaldo CR; Gbadero D; Kingsley LA; Ndimbie O; Howard C; Montemayor PC; Langer A; Sibolboro W
    Epidemiol Infect; 1993 Apr; 110(2):373-8. PubMed ID: 8472780
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of HIV infection in patients attending an inner city accident and emergency department.
    Poznansky MC; Torkington J; Turner G; Bankes MJ; Parry JV; Connell JA; Touquet R; Weber J
    BMJ; 1994 Mar; 308(6929):636. PubMed ID: 8148714
    [No Abstract]   [Full Text] [Related]  

  • 51. HIV seroprevalence among high-risk groups in Kohgiloyeh and Boyerahmad Province, Southwest of Iran, a behavioral surveillance survey.
    Ilami O; Sarkari B; Khosravani A; Tori MA; Hosseini Z
    AIDS Behav; 2012 Jan; 16(1):86-90. PubMed ID: 21190072
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Temporal and geographical trends of anti-HIV-1 antibodies screening among newborns in Italy, 1990-1993. Italian Collaborative Study Group for HIV Prevalence in Newborns.
    Ippolito G; Stegagno M; Girardi E; Costa F; Ravà L; Aebischer ML; Guzzanti E
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 May; 12(1):63-8. PubMed ID: 8624763
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The antibody response in HIV-1 infection.
    Burton DR; Montefiori DC
    AIDS; 1997; 11 Suppl A():S87-98. PubMed ID: 9451972
    [No Abstract]   [Full Text] [Related]  

  • 54. Prevalence of antibody to HIV-1 among entrants to US correctional facilities.
    Vlahov D; Brewer TF; Castro KG; Narkunas JP; Salive ME; Ullrich J; Muñoz A
    JAMA; 1991 Mar; 265(9):1129-32. PubMed ID: 1995998
    [TBL] [Abstract][Full Text] [Related]  

  • 55. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1996 Sep; 276(10):774. PubMed ID: 8769577
    [No Abstract]   [Full Text] [Related]  

  • 56. AIDS and HIV-1 antibody reports--United Kingdom.
    CDR (Lond Engl Wkly); 1991 Feb; 1(6):27-9. PubMed ID: 1669825
    [No Abstract]   [Full Text] [Related]  

  • 57. HIV-1 cross-neutralizing antibodies in German HIV-1-infected patients do not correlate with an antibody-binding pattern against different HIV-1 isolates.
    Jurkiewicz E; Petry H; Sutor GC; Lang S; Schedel I; Hunsmann G
    AIDS; 1995 Jan; 9(1):91-3. PubMed ID: 7893448
    [No Abstract]   [Full Text] [Related]  

  • 58. [Screening for HIV-1 antibodies in recipients of potentially HIV infected preserved blood].
    Grunenberg R; Krüger J
    Beitr Infusionsther; 1990; 26():12-4. PubMed ID: 1703809
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Screening for human immunodeficiency virus antibody in urine.
    Berrios DC; Avins AL; Haynes-Sanstad K; Eversley R; Woods WJ
    Arch Pathol Lab Med; 1995 Feb; 119(2):139-41. PubMed ID: 7848060
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HIV-2 infection in Thailand.
    Chanbancherd P; Limpairojn N; Benenson M; Jugsudee A; Julananto P; Tienamporn P; Luecha W; Tasaniyananda C
    Asian Pac J Allergy Immunol; 2000 Dec; 18(4):245-8. PubMed ID: 11316046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.